Aditya Puri is an Investments Director at Xeraya Capital; he joined the company in October 2012.
Previously, he was a Director in Khazanah Nasional’s Life Sciences group, which is responsible for the organization’s Life Sciences investments. His 20 years of professional experience encompass accomplishments in entrepreneurial ventures and startups, general management, and corporate investing.
He has held positions of increasing responsibility and leadership in Medtech, Telecom and Technology, and Cleantech sectors in organizations of varying sizes. Although based in the US, Aditya has had considerable international experience, including short-term and long-term overseas assignments. Prior to Khazanah, Aditya was working with Cleantech and Healthcare startups affiliated with Harvard and MIT. He evaluated new technologies and advised inventors of high potential startups, and consulted on growth, customer acquisition and commercialization strategies. He was also part of the leadership team at Yankee Group, a global technology research and consulting company, where he launched and had full P&L responsibility for one its high growth and most profitable business units. Earlier at the company, as a consultant covering Asia Pacific, he advised clients on market entry, due diligence, and investment related decisions.
At Boston Scientific, a Fortune 500 medical device manufacturer, Aditya was part of a five-member team reporting to the CFO chartered with the company’s inorganic growth and corporate development activities. In this role, he identified and closed new investment opportunities, and was instrumental in deals that have, in addition to high returns, resulted in significant long-term value for the company.
Aditya has spent most of his life in the Northeast US after moving there from India for education. He has a B.S. from the University of Southern Maine, graduating Summa Cum Laude, and received his MBA from the MIT Sloan School of Management. He has also passed all parts of the U.S. Uniform CPA Examination.